Brian Neel - Apr 29, 2022 Form 4/A - Amendment Insider Report for MARAVAI LIFESCIENCES HOLDINGS, INC. (MRVI)

Role
Chief Operating Officer, Nucleic Acid Production
Signature
/s/ Kurt Oreshack, by power of attorney for Brian Neel
Stock symbol
MRVI
Transactions as of
Apr 29, 2022
Transactions value $
$13,127
Form type
4/A - Amendment
Date filed
6/27/2022, 07:55 PM
Date Of Original Report
Jun 27, 2022
Previous filing
Jan 27, 2022
Next filing
Nov 9, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MRVI Class A Common Stock Award $13.1K +572 +3.2% $22.95 18.5K Apr 29, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Amended to note that this is a voluntary filing. The Reporting Person is voluntarily reporting the acquisition of shares of the Issuer's Class A Common Stock pursuant to the Maravai LifeSciences Holdings, Inc. 2020 Employee Stock Purchase Plan. The acquisition of those 572 shares of Class A Common Stock was exempt pursuant to Rule 16b-3.

Remarks:

Chief Operating Officer, Nucleic Acid Production